Cargando…

p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology

Detalles Bibliográficos
Autores principales: Saleme, Bruno, Das, Subhash K., Zhang, Yongneng, Boukouris, Aristeidis E., Lorenzana Carrillo, Maria Areli, Jovel, Juan, Wagg, Cory S., Lopaschuk, Gary D., Michelakis, Evangelos D., Sutendra, Gopinath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792244/
https://www.ncbi.nlm.nih.gov/pubmed/32750288
http://dx.doi.org/10.1161/JAHA.120.017247
_version_ 1783633762424193024
author Saleme, Bruno
Das, Subhash K.
Zhang, Yongneng
Boukouris, Aristeidis E.
Lorenzana Carrillo, Maria Areli
Jovel, Juan
Wagg, Cory S.
Lopaschuk, Gary D.
Michelakis, Evangelos D.
Sutendra, Gopinath
author_facet Saleme, Bruno
Das, Subhash K.
Zhang, Yongneng
Boukouris, Aristeidis E.
Lorenzana Carrillo, Maria Areli
Jovel, Juan
Wagg, Cory S.
Lopaschuk, Gary D.
Michelakis, Evangelos D.
Sutendra, Gopinath
author_sort Saleme, Bruno
collection PubMed
description
format Online
Article
Text
id pubmed-7792244
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77922442021-01-15 p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology Saleme, Bruno Das, Subhash K. Zhang, Yongneng Boukouris, Aristeidis E. Lorenzana Carrillo, Maria Areli Jovel, Juan Wagg, Cory S. Lopaschuk, Gary D. Michelakis, Evangelos D. Sutendra, Gopinath J Am Heart Assoc Research Letter John Wiley and Sons Inc. 2020-07-29 /pmc/articles/PMC7792244/ /pubmed/32750288 http://dx.doi.org/10.1161/JAHA.120.017247 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Letter
Saleme, Bruno
Das, Subhash K.
Zhang, Yongneng
Boukouris, Aristeidis E.
Lorenzana Carrillo, Maria Areli
Jovel, Juan
Wagg, Cory S.
Lopaschuk, Gary D.
Michelakis, Evangelos D.
Sutendra, Gopinath
p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology
title p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology
title_full p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology
title_fullStr p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology
title_full_unstemmed p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology
title_short p53‐Mediated Repression of the PGC1A (PPARG Coactivator 1α) and APLNR (Apelin Receptor) Signaling Pathways Limits Fatty Acid Oxidation Energetics: Implications for Cardio‐oncology
title_sort p53‐mediated repression of the pgc1a (pparg coactivator 1α) and aplnr (apelin receptor) signaling pathways limits fatty acid oxidation energetics: implications for cardio‐oncology
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792244/
https://www.ncbi.nlm.nih.gov/pubmed/32750288
http://dx.doi.org/10.1161/JAHA.120.017247
work_keys_str_mv AT salemebruno p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology
AT dassubhashk p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology
AT zhangyongneng p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology
AT boukourisaristeidise p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology
AT lorenzanacarrillomariaareli p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology
AT joveljuan p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology
AT waggcorys p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology
AT lopaschukgaryd p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology
AT michelakisevangelosd p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology
AT sutendragopinath p53mediatedrepressionofthepgc1appargcoactivator1aandaplnrapelinreceptorsignalingpathwayslimitsfattyacidoxidationenergeticsimplicationsforcardiooncology